Suneva Medical Introduces ReGenica™, the Next Generation of Growth Factor Skincare

SAN DIEGO, June 6, 2012 /PRNewswire/ -- Suneva Medical, a privately-held aesthetics company, has launched ReGenica Skincare, a three-product breakthrough anti-aging rejuvenation system, developed by the inventor of the key ingredient in TNS. ReGenica contains a highly potent, unique variety of proteins and growth factors in a serum-free solution. It is clinically proven to help reverse the signs of aging and aid in scarless wound healing. The product is available only through physician offices.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/suneva-medical-introduces-regenica-the-next-generation-of-growth-factor-skincare-157356985.html

ReGenica's Multipotent CCM Complex™ represents the next generation of growth factor skincare. The technology was developed by Dr. Gail K. Naughton, a pioneer in the field of regenerative medicine. Suneva Medical licensed ReGenica from Histogen Inc. in March 2012, expanding its portfolio of unique aesthetic products.

"Dr. Naughton is a well renowned regenerative medicine scientist and her research has helped advance the skincare industry. ReGenica's groundbreaking technology is both a novel advance and an ideal fit for our growing portfolio of highly differentiated aesthetic products. Suneva continues to strive to move into the future by offering our customers unique aesthetic products proven to help manage the appearance of aging," commented Nicholas Teti, Chairman and Chief Executive Officer of Suneva Medical.

ReGenica is not simply another line of products with a promise of improved aesthetic results. Clinical studies have demonstrated ReGenica to deliver proven, measurable results in skin rejuvenation. In one study, ReGenica Advanced Rejuvenation Day Repair SPF 15 & Overnight Repair have been shown to reduce the appearance of fine lines and wrinkles, improve skin tone and generate smoother skin over a ten (10) week period.  In two published studies, ReGenica Facial Rejuvenation Complex Post Procedure has been found to improve healing and more rapid re-epithelialization as early as three (3) days post procedure.

Mr. Teti continued, "ReGenica is the next generation of regenerative medicine products and has the potential to change the topical aesthetics landscape."

To learn more about ReGenica visit www.ReGenica.com or follow us on Facebook and Twitter.

About Suneva Medical
Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the dermatology, plastic and cosmetic surgery markets. The Company currently markets Artefill®, Refissa® and ReGenica™ Skincare in the U.S. and Bellafill™ in Canada. For more information visit www.sunevamedical.com.

Media Contacts:
Kate Gilbert
Vice President, Marketing
Suneva Medical
Phone: (858) 550-9999 x7844
or
Kellie Walsh
Phone: (914) 315-6072
[email protected]

Related Links
ReGenica website
Suneva Medical website

SOURCE Suneva Medical